CORDIS Project
Funding breakdown and partner intelligence are Premium
Sign in and upgrade to Premium for EU contribution totals, consortium analytics, OpenAlex research context, and AI summaries. · 0 consortium intelligence fields visible of 1
Start free • Cancel anytime • 14-day refund guarantee
DecipherAD investigates Alzheimer’s disease subtypes through cerebrospinal fluid proteomics to understand their distinct mechanisms and cognitive decline. The project aims to develop blood markers for subtype detection and assess tailored treatments based on these subtypes, potentially revolutionizing therapeutic appro…
Worldwide, 50 million people suffer from dementia, which is caused by Alzheimer’s disease (AD) in 70% of the cases.
There is no treatment to stop, reverse or prevent AD. AD is pathologically defined by amyloid plaques and tau tangles in the brain, implying that it is a single disease entity.
Still, patients vary greatly in rate of decline and underlying pathophysiology, which hampers the search for cures. I have discovered and replicated 5 AD subtypes in patients based on cerebrospinal fluid pro…
Partner organizations (coordinator is shown above), with normalized type and CORDIS activity type. Guests see up to 4 partners.
Norway, Bergen
Type: University / higher education
Activity type: Higher or Secondary Education Establishments
SME: No
Similar projects, consortium collaboration history, frequent partners, and OpenAlex research context.
Guests see up to 5 EuroSciVoc fields.
Guests see up to 5 topics.
Guests see up to 5 keywords.
